Summit Therapeutics Share Discussion Threads

[algernon2] 22/11/2017 17:28

Yes please.

[hugus maximus] 22/11/2017 16:51

Another day ... another dollar?

[hugus maximus] 20/11/2017 22:23

Also a strong end to the day on NASDAQ @ $11.79. Perhaps this is truly the turn around?
Fingers crossed.

[chrisatrdg] 20/11/2017 20:02

luminoso I also thought that the RNS had a certain gravitas about it & feel that we could possible be getting positive news 1st Quarter next year.

Edit: Lets hope tonights NASDAQ close will bump start the share price on AIM in the morning but clearly momentum is building up stateside.

[luminoso] 20/11/2017 19:44

I would guess that it's because there was a confident tone to the RNS and that can be a catalyst for a change in sentiment for the stock. But wtfdik.

[hugus maximus] 20/11/2017 18:50

Is the NASDAQ finally anticipating 24 wk DMD P2 Trial results? I can't second guess any will or reason with this share anymore.

[waterloo01] 20/11/2017 16:54

Looking perky over there! $11.63 at the moment.

[chrisatrdg] 20/11/2017 12:15

Todays RNS must surely be good news as it shows once again Summit are on track for their DMD roll out & that there were no complications.

[chrisatrdg] 17/11/2017 19:49

Action Duchenne launches new Research Strategy for Duchenne muscular dystrophy link below:



The report mentions Summit as part of many other scientific options which shows how much there is for analysts to absorb.

[waterloo01] 17/11/2017 17:42

And up she goes as we close. Just a gut feeling but do suspect the 2nd broker is about the end game here (having recently raised along with milestones fromSRPT and the $30m + from Barda, they are cashed up) so IF anything behind it, it's 'corporate'.

[luminoso] 16/11/2017 22:49

The second broker is very proud of their deal making, whether big or small.

[chrisatrdg] 16/11/2017 21:39

Summit tweet this evening:

Summit Therapeutics‏
@Summitplc
1h1 hour ago

Summit Therapeutics Retweeted Duchenne UK
Proud to be involved with such an important initiative for those living #Duchenne!Summit Therapeutics added,
Duchenne UK
Verified account

@DuchenneUK
Duchenne UK launches Project HERCULES to help patients get faster access to potentially life-changing treatments... hxxp://fb.me/zFFZKy3f
0 replies 0 retweets 0 likes

[chrisatrdg] 16/11/2017 21:34

Well waterloo01 if you think there is 'something afoot' with the 2nd broker it also supports my view that you could be right or its simply all for administration purposes or something similar.

My question is what can a second broker do that the first cannot do or is one to cover the US & the other UK in other words why is the second broker something to start us all thinking why?

[algernon2] 16/11/2017 21:07

Who's "Sue What" Waterloo and where does she come into the picture?

[waterloo01] 16/11/2017 19:52

Somethings afoot with the 2nd broker on AIM, just not sue what!

[chrisatrdg] 16/11/2017 15:04

I agree with your comment Hyper A1 about 'very unstable times ahead' & last night I attended a presentation at Regents University London being an 'iCES and Senior European Experts Seminar' title 'Europe After the Shocks'.During the discussion it was suggested that there were 'fears of a total melt down' in the UK 'politically & economicaly'in the near future.Watch this space.

[luminoso] 16/11/2017 14:08

I agree, chris.
FWIW, I think it makes sense for DMD to be sold off to Sarepta, who with their contacts, lobbyists, and financial clout will get it approved so much more quickly. With that money, the C.Diff programme could be progressed in house
I can't see many major shareholders standing in the way of DMD being sold off, if the price was right.
I am still wondering what else Sarepta could have in mind for the proceeds of their recent fundraising.

[chrisatrdg] 16/11/2017 13:26

Hi luminoso - My post this morning is a result of comments on this board & 'the other board' plus conversations with people on this board & 'the other board' at various recent AGM's.It is all conjecture but I sense that something is brewing.

[chrisatrdg] 16/11/2017 13:22

Summit tweet today:

It's World #AntibioticAwarenessWeek! While #Cdiff is not yet affected by #AntibioticResistance, the use of vancomycin and metronidazole to treat C. diff could drive resistance for other bacteria. Precision antibiotics like ridinilazole are in need!

[luminoso] 16/11/2017 13:19

interesting, chris. Where are these hunches coming from ?

[chrisatrdg] 16/11/2017 12:34

Todays RNS

Following up on this mornings posts it appears that something is happening but not sure what I had a sense that the US side is pulling away on DMD to be fed by Summit (Oxford) Ltd (subsidiary of the plc) & is the operating company of the group.With US side being DMD it would then lead Summit in the UK to continue with C-Diff.However I am not sure it is likely as my understanding is that the principle investors in Summit wanted to see DMD through to production.It is all speculation maybe the next quarters accounts in late November or December may shed further light on where we are.

[phowdo] 16/11/2017 09:53

Perhaps an effort to make the shareprice "high"...

;)

[hugus maximus] 16/11/2017 09:36

Anyone care to comment on the significance of having a "joint" broker?

[makingmillions] 16/11/2017 09:09

Anything to be made of that news?